This is the first treatment approved to help patients with erythropoietic protoporphyria increase their exposure to light.
The approval is based on results from a pair of randomized, double-blind, placebo-controlled, phase 3 studies involving 657 adult patients with...
Translating the 2019 AAD-NPF Guidelines of Care for the Management of Psoriasis With Biologics to Clinical Practice
In February 2019, the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) released a novel set of guidelines...
SEATTLE – Culture draws were associated with a 20% increase in hospital length of stay.
AUSTIN – Survey respondents self-diagnosed a number of dermatologic conditions based on their time spent online.
AUSTIN, TX – The median length of stay for patients was 2 days, with a median cost of $6,289.50 for each case.
MILAN – The nonsteroidal investigative drug SNA-120 helped with psoriasis severity, burning, and pain.
With the highest measles cases in the 21st century seen in Europe last year, the CDC is urging all U.S. travelers there to be sure they’re fully...
Acute graft-vs-host disease (GVHD) is more common in allogeneic stem cell transplantation but can occur in the setting of solid-organ...